MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Stevanato Group S.p.A. Ordinary Shares (NY:STVN)

20.91 -0.50 (-2.34%)
Streaming Delayed Price Updated: 11:14 AM EDT, Sep 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 24,662
Open 21.25
Bid (Size) 20.89 (600)
Ask (Size) 21.08 (600)
Prev. Close 21.41
Today's Range 20.89 - 21.39
52wk Range 12.89 - 27.99
Shares Outstanding 295,540,036
Dividend Yield 0.30%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Stevanato Group to Participate in Two Upcoming Investor Conferences
From Stevanato Group S.p.A.
Via Business Wire
News headline image
Stevanato Group Q2 Earnings Call Highlights ↗
Stevanato Group (NYSE:STVN) reported second-quarter 2026 revenue growth of 8% as demand for higher-value drug containment and delivery products helped lift profitability, while the company updated its... 
Via MarketBeat
Topics Earnings

Performance

YTD
+1.6%
+1.6%
1 Month
-2.4%
-2.4%
3 Month
+20.4%
+20.4%
6 Month
+55.2%
+55.2%
1 Year
-18.0%
-18.0%

More News

Read More
News headline image
Stevanato (STVN) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Earnings Scheduled For November 6, 2025 ↗
Via Benzinga
News headline image
Stevanato Group Q2 2026 Earnings Call: Complete Transcript ↗
Via Benzinga
Topics Earnings
News headline image
Stevanato Group Delivers 8% Revenue Growth for the Second Quarter of Fiscal 2026
From Stevanato Group S.p.A.
Via Business Wire
News headline image
Liraglutide Combination Products Incorporating Stevanato Group's Alina® Pen Injector Received Marketing Authorizations in Multiple European Countries
From Stevanato Group S.p.A.
Via Business Wire
News headline image
Stevanato Group to Report Second Quarter 2026 Financial Results on August 4, 2026
From Stevanato Group S.p.A
Via Business Wire
News headline image
2 Dirt Cheap Healthcare Stocks to Buy With $1,000 Right Now ↗
Via The Motley Fool
Topics Economy
News headline image
Stevanato Group Introduces Deora™, a Pen Injector for Subcutaneous Delivery in Diabetes and Weight Management
From Stevanato Group
Via Business Wire
News headline image
Stevanato Group Announces Results of Ordinary and Extraordinary Shareholders’ Meeting
From Stevanato Group S.p.A.
Via Business Wire
News headline image
Stevanato (STVN) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
Topics World Trade
News headline image
Stevanato Group Delivers 7% Revenue Growth (10% at Constant Currency) for the First Quarter of Fiscal 2026
From Stevanato Group S.p.A.
Via Business Wire
News headline image
Stevanato Group to Participate in Three Upcoming Investor Conferences
From Stevanato Group S.p.A.
Via Business Wire
News headline image
Stevanato Group to Report First Quarter 2026 Financial Results on May 7, 2026
From Stevanato Group
Via Business Wire
News headline image
Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum
From Stevanato Group S.p.A.
Via Business Wire
News headline image
End of an Era: West Pharmaceutical Shares Slide as Longtime CEO Eric Green Announces Retirement
Via MarketMinute
Topics Economy Retirement
News headline image
Stevanato (STVN) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Stevanato Group Delivers 7% Revenue Growth (9% at Constant Currency) for Fiscal Year 2025, Including Record Revenue from High-Value Solutions and Expanded Margins
From Stevanato Group S.p.A.
Via Business Wire
News headline image
Stevanato Group to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 4, 2026
From Stevanato Group
Via Business Wire
News headline image
The Biotech Revolution’s Ultimate ‘Picks and Shovels’ Play: A Deep Dive into West Pharmaceutical Services (WST)
Via MarketMinute
Topics Economy
News headline image
Picks and Shovels of the Biotech Revolution: A Deep Dive into West Pharmaceutical Services (WST)
Via PredictStreet
Topics Economy Intellectual Property Supply Chain
News headline image
Stevanato (STVN) Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings World Trade
News headline image
Stevanato Group SPA (NYSE:STVN) Tops Q3 2025 Earnings and Revenue Estimates ↗
Via Chartmill
News headline image
Stevanato Group Reports Revenue of €303.2 Million for the Third Quarter of 2025
From Stevanato Group S.p.A.
Via Business Wire

Frequently Asked Questions

Is Stevanato Group S.p.A. Ordinary Shares publicly traded?
Yes, Stevanato Group S.p.A. Ordinary Shares is publicly traded.
What exchange does Stevanato Group S.p.A. Ordinary Shares trade on?
Stevanato Group S.p.A. Ordinary Shares trades on the New York Stock Exchange
What is the ticker symbol for Stevanato Group S.p.A. Ordinary Shares?
The ticker symbol for Stevanato Group S.p.A. Ordinary Shares is STVN on the New York Stock Exchange
What is the current price of Stevanato Group S.p.A. Ordinary Shares?
The current price of Stevanato Group S.p.A. Ordinary Shares is 20.91
When was Stevanato Group S.p.A. Ordinary Shares last traded?
The last trade of Stevanato Group S.p.A. Ordinary Shares was at 09/29/26 11:14 AM ET
What is the market capitalization of Stevanato Group S.p.A. Ordinary Shares?
The market capitalization of Stevanato Group S.p.A. Ordinary Shares is 6.18B
How many shares of Stevanato Group S.p.A. Ordinary Shares are outstanding?
Stevanato Group S.p.A. Ordinary Shares has 6B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story